Postdoctoral in Cancer Bioinformatics

Organization
Catalan Institute of Oncology
Job Location
Gran via 199
Hospital Duran i Reynals
08908 L'Hospitalet de Llobregat Barcelona
Spain
Salary
28-34.000 EUR/year
Benefits

The call offers highly competitive and attractive salary and working conditions. The successful candidates will receive a salary in accordance with the regulations for early stage researchers. Exact salary will be confirmed upon appointment.

Job Description

Successful candidates will have the opportunity to initiate and conduct high-quality research within ProCURE (Program Against Cancer Therapeutic Resistance) at the Catalan Institute of Oncology: Dr. Pujana's group. Successful candidates will join a newly created translational research program focused on finding novel, advanced and personalized therapeutic strategies against cancer resistance. ProCURE involves strong clinical interactions and multidisciplinary approaches. The program offers a stimulating research atmosphere and an environment in which collaboration and exchange of ideas and techniques is actively encouraged with a strong commitment to translational research, which overall provides a lively and stimulating environment for young talents.

Dr. Pujana leads the Breast Cancer and Systems Biology research lab at the Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL) and, complementarily, leads a newly created ICO Research Program Against Cancer Therapeutic Resistance (ProCURE). This program consists of nine research groups with more than 700 peer-review publications. The overall aim of the research group is to better understand breast cancer development, the emergence of subtypes, and their therapeutic response/resistance. Particularly, the group’s research is focused on triple-negative and BRCA1-mutated (germline) breast cancer, which is in accordance to the current proposal. The group works on deciphering the molecular mechanisms that are perturbed at the germline level (by common genetic variation and rare mutations) influencing breast cancer risk, again particularly in BRCA1 mutation carriers (i.e. genetic modifiers of BRCA1 mutations penetrance). As such, the group is member of the international Consortium of Investigators of BRCA1/2 Modifiers (CIMBA), which also complements the proposed study.

Requirements

Academic degree:

-       A PhD or Master degree in the field of cancer biology (including mathematics, physics and statistics).

-         Strong writing skills are mandatory.

 Requirements and expertise:

-         Significant record of scientific publications is required and at least first-author 2 publications in international and peer-reviewed journals.

-         Strong background in statistics. 

Mobility:

-         Candidates can be of any nationality. 

Language skills:

-         The candidate is expected to communicate fluently and flawlessly in English

About Our Organization

The Catalan Institute of Oncology (ICO, Barcelona) is a public center working exclusively in the field of cancer. Its approach to the disease is comprehensive, combining, all in one organization, prevention, care, specialized training and research. At present the ICO has four centers that work jointly with four university hospitals. It has its own territorial model and it is a multi-centric organization working in a coordinated way with 18 hospitals of the territory. Currently, ICO is an oncology referral center for 40% of the adult population of Catalonia. Research features as part of the primordial objective of the ICO, as stated in its founding Articles of Association.

ICO was founded in 1996 and it has become a center of reference in Catalonia, both in healthcare quality (satisfaction survey results and award for Best Clinical Practices from the National Health System, among others) and in research (top Spanish hospital-institute in terms of scientific quality). ICO has a strong track record of cooperation with other academic groups, with private companies and with public administration at international level, with partners in Europe and the Americas.

ICO carries out research in all areas of cancer, from understanding why it develops and how to prevent it, to finding early diagnosis strategies or new, more efficient treatments, as well as research related to caring for end-of-life patients. It also carries out research in nursing, psycho-oncology and social work.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.